Right, or maybe they are just using "short" colloquially to mean selling at key levels of technical resistance after buying lower. Can't fault them for that - no one ever went broke selling for a gain. It's just a different approach (trading vs. investing).

In the long run, they won't matter if leronlimab is all that we believe it can be.